,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
154,.,.,HGMD|OMIM,Name=GCcontent,.,CSS16156100102,236200,"Homocystinuria, B6-responsive and nonresponsive types;Thrombosis, hyperhomocysteinemic","1.$$$mimNumber,236200###prefix,####preferredTitle,HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY###inheritance,Autosomal recessive ###growthHeight,Normal to tall stature ###growthOther,Occasional failure to thrive in infancy ###headAndNeckEyes,Ectopia lentis ;###headAndNeckEyes,Myopia ;###headAndNeckEyes,Glaucoma ###headAndNeckMouth,High-arched palate ###headAndNeckTeeth,Crowded teeth ###cardiovascularHeart,Myocardial infarction ;###cardiovascularHeart,Mitral valve prolapse ###chestRibsSternumClaviclesAndScapulae,Pectus excavatum ;###chestRibsSternumClaviclesAndScapulae,Pectus carinatum ###abdomenExternalFeatures,Inguinal hernia ###abdomenLiver,Fatty changes in liver ###abdomenPancreas,Pancreatitis ###skeletal,Generalized osteoporosis ###skeletalSpine,Biconcave 'codfish' vertebrae ;###skeletalSpine,Kyphoscoliosis ###skeletalLimbs,Dolichostenomelia ;###skeletalLimbs,Arachnodactyly ;###skeletalLimbs,Limited joint mobility ###skinNailsHairSkin,Hypopigmentation ;###skinNailsHairSkin,Malar flush ;###skinNailsHairSkin,Livedo reticularis ###skinNailsHairHair,Hypopigmentation ;###skinNailsHairHair,Fine, brittle hair ###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Cerebrovascular accident ###neurologicBehavioralPsychiatricManifestations,Psychiatric disorders ;###neurologicBehavioralPsychiatricManifestations,Depression ;###neurologicBehavioralPsychiatricManifestations,Personality disorder ###hematology,Thromboembolism (25%) ###laboratoryAbnormalities,Homocystinuria ;###laboratoryAbnormalities,Methioninuria ;###laboratoryAbnormalities,Cystathionine beta-synthase deficiency ###miscellaneous,Fifty-percent of individuals responsive to pyridoxine (vitamin B6) ;###miscellaneous,Pyridoxine responsive individuals often have milder manifestations than those not responsive ;###miscellaneous,Management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders ;###miscellaneous,Treatment with betaine, especially for pyridoxine nonresponders ;###miscellaneous,Thromboembolism is the most common cause of death ;###miscellaneous,Frequency between 1 in 58,000 to 1 in 1,000,000 ###molecularBasis,Caused by mutation in the cystathionine beta-synthase gene (CBS, ) 2.$$$mimNumber,236200###prefix,####preferredTitle,HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY###inheritance,Autosomal recessive ###growthHeight,Normal to tall stature ###growthOther,Occasional failure to thrive in infancy ###headAndNeckEyes,Ectopia lentis ;###headAndNeckEyes,Myopia ;###headAndNeckEyes,Glaucoma ###headAndNeckMouth,High-arched palate ###headAndNeckTeeth,Crowded teeth ###cardiovascularHeart,Myocardial infarction ;###cardiovascularHeart,Mitral valve prolapse ###chestRibsSternumClaviclesAndScapulae,Pectus excavatum ;###chestRibsSternumClaviclesAndScapulae,Pectus carinatum ###abdomenExternalFeatures,Inguinal hernia ###abdomenLiver,Fatty changes in liver ###abdomenPancreas,Pancreatitis ###skeletal,Generalized osteoporosis ###skeletalSpine,Biconcave 'codfish' vertebrae ;###skeletalSpine,Kyphoscoliosis ###skeletalLimbs,Dolichostenomelia ;###skeletalLimbs,Arachnodactyly ;###skeletalLimbs,Limited joint mobility ###skinNailsHairSkin,Hypopigmentation ;###skinNailsHairSkin,Malar flush ;###skinNailsHairSkin,Livedo reticularis ###skinNailsHairHair,Hypopigmentation ;###skinNailsHairHair,Fine, brittle hair ###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Cerebrovascular accident ###neurologicBehavioralPsychiatricManifestations,Psychiatric disorders ;###neurologicBehavioralPsychiatricManifestations,Depression ;###neurologicBehavioralPsychiatricManifestations,Personality disorder ###hematology,Thromboembolism (25%) ###laboratoryAbnormalities,Homocystinuria ;###laboratoryAbnormalities,Methioninuria ;###laboratoryAbnormalities,Cystathionine beta-synthase deficiency ###miscellaneous,Fifty-percent of individuals responsive to pyridoxine (vitamin B6) ;###miscellaneous,Pyridoxine responsive individuals often have milder manifestations than those not responsive ;###miscellaneous,Management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders ;###miscellaneous,Treatment with betaine, especially for pyridoxine nonresponders ;###miscellaneous,Thromboembolism is the most common cause of death ;###miscellaneous,Frequency between 1 in 58,000 to 1 in 1,000,000 ###molecularBasis,Caused by mutation in the cystathionine beta-synthase gene (CBS, )",https://www.omim.org/entry/236200,.,Autosomal recessive,Het,21,44492252,G,A,.,.,PASS,0/1:17:31,54.84,"a$..,Aa,AaaA,.AA,,AA.a.A.",missense_variant;missense_variant;missense_variant,CBS,875,.,NM_001178009.1(CBS):c.52C>T(p.Arg18Cys);NM_000071.2(CBS):c.52C>T(p.Arg18Cys);NM_001178008.1(CBS):c.52C>T(p.Arg18Cys),NM_000071.2,exon3(18);exon3(17);exon3(17),P+=>P0;P+=>P0;P+=>P0,0.013,0.0026,2,0.00015,0.0008,0.0112,0.0006,0.0111,0,92,0.011,0,95,0.00086,0.00581395348837,4/688,http://exac.broadinstitute.org/variant/21-44492252-G-A,1.38,18.8,7,0.01,http://exac.broadinstitute.org/gene/ENSG00000160200,0.11296,0.0,0.2,T,0.453,P,0.115,B,0.161,N,1.000,N,2.98,5.956,rs201827340,.,.,.,.,NM_000071.2(CBS):c.52C>T(p.R18C),FP,Altered enzyme activity,16205833,.,.,.,.,.,.,.,"COSM1031138,COSM1031139",1(endometrium),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cellular nitrogen compound metabolic process (GO:0034641)|cysteine biosynthetic process from serine (GO:0006535)|cysteine biosynthetic process via cystathionine (GO:0019343)|homocysteine catabolic process (GO:0043418)|homocysteine metabolic process (GO:0050667)|hydrogen sulfide biosynthetic process (GO:0070814)|L-cysteine catabolic process (GO:0019448)|L-serine catabolic process (GO:0006565)|L-serine metabolic process (GO:0006563)|small molecule metabolic process (GO:0044281)|sulfur amino acid metabolic process (GO:0000096)|transsulfuration (GO:0019346),cytosol (GO:0005829)|nucleus (GO:0005634),adenyl nucleotide binding (GO:0030554)|cystathionine beta-synthase activity (GO:0004122)|enzyme binding (GO:0019899)|heme binding (GO:0020037)|identical protein binding (GO:0042802)|metal ion binding (GO:0046872)|modified amino acid binding (GO:0072341)|protein homodimerization activity (GO:0042803)|pyridoxal phosphate binding (GO:0030170)|ubiquitin protein ligase binding (GO:0031625),.,.,.,.,49,1,CSS16156100102
342,.,.,HGMD|OMIM|novel,Name=LowComplexity,.,CSS16156100102,612847,Brachyolmia 4 with mild epiphyseal and metaphyseal changes,"1.$$$mimNumber,612847###prefix,####preferredTitle,BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4###inheritance,Autosomal recessive ###growthHeight,Short stature ###skeletalSpine,Platyspondyly ;###skeletalSpine,Irregular end plates ;###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,Lumbar scoliosis ###skeletalLimbs,Short and bowed lower limbs ;###skeletalLimbs,Enlarged knee joints ;###skeletalLimbs,Metaphyseal changes, mild, of knees and hips ;###skeletalLimbs,Osteoarthropathy, precocious ###skeletalHands,Brachydactyly, mild ###skinNailsHairSkin,Acne ###skinNailsHairHair,Hirsutism ###endocrineFeatures,Hyperandrogenism ;###endocrineFeatures,Premature pubarche (in 1 female patient) ;###endocrineFeatures,Secondary amenorrhea ###laboratoryAbnormalities,Elevated androstenedione and testosterone ;###laboratoryAbnormalities,Dehydroepiandrosterone (DHEA) at upper level of normal range ;###laboratoryAbnormalities,DHEA sulfotransferase below limit of detection ###miscellaneous,Skeletal and endocrine features have not been fully characterized in all of the patients reported ###molecularBasis,Caused by mutation in the 3-prime-phosphoadenosine 5-prime-phosphosulfate synthase 2 gene (PAPSS2, )",https://www.omim.org/entry/612847,.,Autosomal recessive,Hom,10,89473069,-,AAAAAAAA,.,.,strand fail|low coverage,1/1:6:6,100.0,",$.,,,,.,....,.......",splice_region_variant;splice_region_variant,PAPSS2,9060,.,NM_004670.3(PAPSS2):c.381+17_381+24dupAAAAAAAA;NM_001015880.1(PAPSS2):c.381+17_381+24dupAAAAAAAA,NM_001015880.1,intron3(11);intron3(12),.;.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.00290697674419,2/688,.,0.31,22.6,14,0.0,http://exac.broadinstitute.org/gene/ENSG00000198682,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_001015880.1(PAPSS2):c.381+2delT,DM,Brachyolmia,22791835",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)|3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)|blood coagulation (GO:0007596)|bone development (GO:0060348)|carbohydrate metabolic process (GO:0005975)|glycosaminoglycan metabolic process (GO:0030203)|skeletal system development (GO:0001501)|small molecule metabolic process (GO:0044281)|sulfate assimilation (GO:0000103)|xenobiotic metabolic process (GO:0006805),cytosol (GO:0005829),adenylylsulfate kinase activity (GO:0004020)|ATP binding (GO:0005524)|nucleotidyltransferase activity (GO:0016779)|sulfate adenylyltransferase (ATP) activity (GO:0004781),.,.,.,.,40,0,CSS16156100102
380,.,.,low_frequency,.,.,CSS16156100102,.,.,.,.,.,.,Het,8,99158874,T,C,.,.,PASS,0/1:33:69,47.83,"C,,,,,,c,c,,c,C....c,cC,,CccC.ccC,cC,$,C,,c.,cC.C.C.C",missense_variant;missense_variant;missense_variant,POP1,10940,.,NM_001145860.1(POP1):c.1673T>C(p.Ile558Thr);NM_015029.2(POP1):c.1673T>C(p.Ile558Thr);NM_001145861.1(POP1):c.1673T>C(p.Ile558Thr),NM_015029.2,exon12(16);exon12(16);exon12(16),NP=>P0;NP=>P0;NP=>P0,0.006,0.0012,1,0.000077,0.0003,0.0035,0.0003,0.0049,0,26,0.0030,0,27,0.00022,0.0218023255814,15/688,http://exac.broadinstitute.org/variant/8-99158874-T-C,0.25,38.2,19,0.0,http://exac.broadinstitute.org/gene/ENSG00000104356,0.58452,0.0,0.3,T,0.221,B,0.075,B,0.000,D,0.992,D,5.09,16.77,rs192665998,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"RNA phosphodiester bond hydrolysis (GO:0090501)|RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)|tRNA 5'-leader removal (GO:0001682)|tRNA catabolic process (GO:0016078)",extracellular space (GO:0005615)|nucleolar ribonuclease P complex (GO:0005655)|ribonuclease MRP complex (GO:0000172),poly(A) RNA binding (GO:0044822)|ribonuclease MRP activity (GO:0000171)|ribonuclease P activity (GO:0004526),.,.,.,.,54,2,CSS16156100102
